Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,165 shares at $232.35 ($2.2M) on 2020-02-25, disclosed to the SEC on 2020-02-26.
Open-market sale of $2.2M VRTX by EVP and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $239.23 | 2,898 | $693K | 32.1% |
| 2 | $229.72 | 893 | $205K | 9.5% |
| 3 | $229.72 | 893 | $205K | 9.5% |
| 4 | $230.88 | 450 | $104K | 4.8% |
| 5 | $232.35 | 440 | $102K | 4.7% |
| 6 | $234.41 | 660 |
| $155K |
| 7.2% |
| 7 | $234.41 | 660 | $155K | 7.2% |
| 8 | $235.36 | 340 | $80K | 3.7% |
| 9 | $235.36 | 340 | $80K | 3.7% |
| 10 | $236.71 | 320 | $76K | 3.5% |
| 11 | $236.71 | 320 | $76K | 3.5% |
| 12 | $238.28 | 420 | $100K | 4.6% |
| 13 | $238.28 | 420 | $100K | 4.6% |
| 14 | $239.13 | 111 | $27K | 1.2% |
| Total | $235.39 avg | 9,165 | $2.2M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |